Skip to content

AlphaMissense

AlphaMissense is a deep learning method developed by DeepMind for predicting the pathogenicity of missense variants in human proteins.

Freemium · Web

AlphaMissense in short

AlphaMissense covers 71 million possible missense variants, but its accuracy is gene-dependent.
stork
I am one still image.
One typed sentence. This clip cost 5 cents, the minimum per video.
Make a photo talk for 20 cents a minute.
Upload one photo and type the words. No subscription. One free video a day.
Make one freeDevelopers: there is an API

What is AlphaMissense?

AlphaMissense is a deep learning tool developed by Google DeepMind that enables researchers and clinicians to predict the pathogenicity of missense variants in human proteins. It assigns a score between 0 and 1, indicating the likelihood of a variant being disease-causing. This AI model, an adaptation of AlphaFold, is fine-tuned on human and primate variant population frequency databases, combining structural context and evolutionary conservation to classify variants as likely benign or likely pathogenic. Its primary use cases include refining diagnoses for rare genetic disorders, understanding the genetic underpinnings of complex traits, and accelerating research by providing a catalog of all possible 71 million missense variants in the human genome.

Key Features of AlphaMissense

AlphaMissense provides a comprehensive suite of capabilities for genetic variant analysis, leveraging advanced deep learning techniques to offer precise predictions and insights.

  • Predicts the pathogenicity of missense variants in human proteins with a score between 0 and 1.
  • Classifies variants as either likely benign or likely pathogenic.
  • Utilizes a deep learning model adapted from AlphaFold, incorporating structural context.
  • Leverages evolutionary conservation data from human and primate variant population frequency databases.
  • Identifies mutational hot/cold spots within protein structures.
  • Offers analysis, visualization, validation, and benchmarking functionalities for missense mutations.
  • Provides a catalog of all 71 million possible missense variants in the human genome.
  • Ensures data privacy by never training on user-submitted data.

Who Should Use AlphaMissense?

AlphaMissense is designed for professionals engaged in genetic research, clinical diagnostics, and therapeutic development, offering tools to enhance understanding and management of genetic variations.

  • Researchers: To prioritize resources, accelerate studies in molecular biology, clinical, and statistical genetics, and investigate missense mutations in human protein-coding genes.
  • Clinicians: For aiding in patient diagnosis, particularly for rare genetic disorders, and interpreting variants of unknown significance (VUS).
  • Scientists: Working to understand genetic variation and disease, to illuminate how specific amino acid changes impact protein function and to support therapeutic development.

How to Use AlphaMissense

AlphaMissense can be accessed via its web portal or integrated into research workflows through its R package, allowing users to query and analyze missense variant predictions.

  1. Navigate to the AlphaMissense web portal (alphamissense.org).
  2. Search for specific missense variants by gene name, protein identifier, or genomic coordinates.
  3. Review the assigned pathogenicity score (0-1) and classification (likely benign/pathogenic).
  4. Utilize the provided visualization tools to understand the structural context of variants.
  5. Integrate AlphaMissense data into existing research pipelines using the 'AlphaMissenseR' R package for programmatic analysis and comparison with other datasets like ClinVar.

AlphaMissense Pricing & Plans

AlphaMissense operates on a freemium model, providing access to its core prediction capabilities without direct monetary cost for standard usage.

  • Freemium: Access to the AlphaMissense web portal and its comprehensive catalog of missense variant predictions.

Pros

  • High accuracy in predicting pathogenicity, with 90% precision on a large subset of the ClinVar database.
  • Comprehensive coverage, classifying 89% of all 71 million possible missense variants in the human genome.
  • Integration into major biological databases (Ensembl, UniProt, DECIPHER, AlphaFold DB) enhances accessibility and utility.
  • Leverages advanced deep learning and AlphaFold methodology for robust predictions based on structural context.
  • Provides a valuable resource for prioritizing research and aiding in the diagnosis of genetic disorders.

Cons

  • Clinical utility in decision-making still requires additional validation, as highlighted by several studies.
  • Accuracy can be gene-dependent, meaning performance may vary across different genes.
  • The tool does not offer a public API for direct programmatic integration, limiting automated workflows beyond the 'AlphaMissenseR' package.
  • One study noted that it does not rely completely on AlphaFold2's structural contexts, which might impact certain predictions.

AlphaMissense vs Competitors

AlphaMissense distinguishes itself in the landscape of genetic variant prediction tools through its deep learning architecture, foundation in AlphaFold, and comprehensive coverage.

See every AlphaMissense alternative, compared

AlphaMissense

Freemium · Web

From the Stork blog

Enjoying this? Get one like it in your inbox each morning.

one email a day · unsubscribe in two clicks · no third-party tracking